Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2008; 29(04): 45-46
DOI: 10.4103/0971-5851.51410
Letter to the Editor

Cisplatin induced acute cerebral infarct

K Sambasivaiah
Departments of Medical Oncology, Neurology, and Radiology, Narayana Medical College Hospital, Nellore, Andhra Pradesh, India
,
Srikanth Reddy
Departments of Medical Oncology, Neurology, and Radiology, Narayana Medical College Hospital, Nellore, Andhra Pradesh, India
,
B Praveen Kumar
Departments of Medical Oncology, Neurology, and Radiology, Narayana Medical College Hospital, Nellore, Andhra Pradesh, India
,
P Suneetha
Departments of Medical Oncology, Neurology, and Radiology, Narayana Medical College Hospital, Nellore, Andhra Pradesh, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
19 November 2021

© 2008. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Li SH, Chen WH, Tang Y, et al. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients.Clin Neurol Neurosurg. 2006;108(2):150-6.
  • 2 Brouha ME, Bloemendal HJ, Kappelle LJ, Winter JB Cerebral infarction and myocardial infarction due to cisplatin-containingchemotherapy. Ned Tijdschr Geneeskd. 2003;147(10):457-60.
  • 3 Vogelzang NJ, Torkelson JL, Kennedy BJ. Hypomagnesemia, renal dysfunction, and Raynaud′s phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.Cancer. 1985;56(12):2765-70.
  • 4 Taher A, Shamsseddine A, Saghir N, et al. Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report.Eur J Gynaecol Oncol. 1999;20(4):323-4.
  • 5 Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complicationsassociated with cisplatin-based chemotherapy.Oncology. 1985;42(5):296-300.
  • 6 Periard D, Boulanger CM, Eyer S, Amabile N, Pugin P, Gerschheimer C, Hayoz D. Are circulating endothelialderived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke. 2007;38(5):1636-8.
  • 7 Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest. 2003;112(6):853-62.